Evidence map›Paper›PMID 22606276›Full record

Trial reportPloS one2012

Cluster analysis of obesity and asthma phenotypes.

E Rand Sutherland, Elena Goleva, Tonya S King, Erik Lehman, Allen D Stevens, Leisa P Jackson, Amanda R Stream, John V Fahy, Donald Y M Leung, Asthma Clinical Research Network

Registry-linked trialOpen access · goldAbstract readClinical Trial
In one paragraph

Trial report in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02975258 (Adiposity and Airway Inflammation in HIV-Associated Airway Disease), which is not on this map. Cited by 98 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
98citing papers in PubMed, 3 pooled it
11.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02975258 completednot on this mapstarted 2015, after this paper: background citation

Adiposity and Airway Inflammation in HIV-Associated Airway Disease

TypeobservationalSponsorUniversity of PittsburghRan2015 to 2017Enrolled102ConditionsAsthma, HIV, AdiposityArmsBlood draw, Questionnaires, Spirometry, Methacholine challenge test, Quantitative CT scans
3 · Its place in the literature

Who cites it

98 citing papers in PubMed, 3 syntheses or guidelines pooled it, 212 citations in OpenAlex.

  1. Pooled it
  2. Differential gene expression in nasal airway epithelium from overweight or obese youth with asthma.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2022
    Pooled it
  3. Pooled it
  4. Trial
  5. Obesity's effect on asthma extends to diagnostic criteria.The Journal of allergy and clinical immunology · 2018
    Trial
  6. Trial
  7. Safety and efficacy of high-dose leukocytapheresis in patients with refractory asthma.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2014
    Trial
  8. Obesity and adiposity indicators, asthma, and atopy in Puerto Rican children.The Journal of allergy and clinical immunology · 2014
    Trial
  9. Article
  10. Article
  11. Article
  12. Asthma Phenotypes and Biomarkers.Respiratory care · 2025
    Review
  13. Article
  14. Diabetes-inducing effects of bronchial asthma.World journal of diabetes · 2025
    Article
  15. Review
  16. Article
  17. Weight Loss Interventions for Adults With Obesity-Related Asthma.The journal of allergy and clinical immunology. In practice · 2024
    Article
  18. Review
  19. Article
  20. Type 1 Error on Type 2 Inflammation: Circular Analysis in Asthma Clustering.American journal of respiratory and critical care medicine · 2023
    Article

38 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

E Rand SutherlandDepartment of Medicine, National Jewish Health, Denver, Colorado, United States of America. sutherlande@njhealth.org
Elena Goleva
Tonya S King
Erik Lehman
Allen D Stevens
Leisa P Jackson
Amanda R Stream
John V Fahy
Donald Y M Leung
Asthma Clinical Research Network
University of Colorado Denver · USPennsylvania State University · USNational Jewish Health · USUniversity of California, San Francisco · US

Funding

CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR025780 · NCRR · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2008 to 2011
$61.3M
INSTITUTIONAL CTSA (UW-MADISON): CLINICAL TRIALSUL1RR025011 · NCRR · UNIVERSITY OF WISCONSIN-MADISON · PI DREZNER, MARC KENNETH · 2007 to 2011
$29.5M
ACRN Data Coordinating CenterU10HL074231 · NHLBI · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI CHINCHILLI, VERNON M. · 2003 to 2007
$13.3M
Informative Clinical Studies in AsthmaU10HL074227 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI ISRAEL, ELLIOT · 2003 to 2007
$5.8M
Treatment of Severe Persistent AsthmaU10HL074212 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI LEMANSKE, ROBERT F · 2003 to 2007
$4.9M
Innovative Investigations and Therapies for AsthmaU10HL074073 · NHLBI · NATIONAL JEWISH HEALTH · PI MARTIN, RICHARD J · 2003 to 2007
$3.9M
Asthma Clinical Research Network Center at UCSFU10HL074204 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BOUSHEY, HOMER A · 2003 to 2007
$3.8M
Asthma Clinical Research NetworkU10HL074206 · NHLBI · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI CALHOUN, WILLIAM J · 2003 to 2008
$3.6M
Asthma Clinical Research Network-Washington UniversityU10HL074208 · NHLBI · WASHINGTON UNIVERSITY · PI CASTRO, MARIO · 2003 to 2007
$3.4M
ASTHMA CLINICAL RESEARCH NETWORKU10HL074218 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI WASSERMAN, STEPHEN I · 2003 to 2012
$3.3M
Asthma Clinical Research Network (ACRN)U10HL074225 · NHLBI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI PETERS, STEPHEN P · 2003 to 2007
$3.2M
Mechanisms of steroid resistant asthmaR01AI070140 · NIAID · NATIONAL JEWISH HEALTH · PI LEUNG, DONALD YM · 2007 to 2011
$2.5M
NCRR NIH HHS RR025011NCRR NIH HHS RR025780NCRR NIH HHS UL1 RR025011NCRR NIH HHS UL1 RR025780NHLBI NIH HHS HL074073NHLBI NIH HHS HL074204NHLBI NIH HHS HL074206NHLBI NIH HHS HL074208NHLBI NIH HHS HL074212NHLBI NIH HHS HL074218NHLBI NIH HHS HL074225NHLBI NIH HHS HL074227NHLBI NIH HHS HL074231NHLBI NIH HHS HL090982NHLBI NIH HHS R01 HL090982NHLBI NIH HHS U10 HL074073NHLBI NIH HHS U10 HL074204NHLBI NIH HHS U10 HL074206NHLBI NIH HHS U10 HL074208NHLBI NIH HHS U10 HL074212NHLBI NIH HHS U10 HL074218NHLBI NIH HHS U10 HL074225NHLBI NIH HHS U10 HL074227NHLBI NIH HHS U10 HL074231NIAID NIH HHS AI070140NIAID NIH HHS R01 AI070140NIAID NIH HHS R56 AI070140
6 · The paper itself

Abstract

backgroundAsthma is a heterogeneous disease with variability among patients in characteristics such as lung function, symptoms and control, body weight, markers of inflammation, and responsiveness to glucocorticoids (GC). Cluster analysis of well-characterized cohorts can advance understanding of disease subgroups in asthma and point to unsuspected disease mechanisms. We utilized an hypothesis-free cluster analytical approach to define the contribution of obesity and related variables to asthma phenotype. METHODOLOGY AND PRINCIPAL

findingsIn a cohort of clinical trial participants (n = 250), minimum-variance hierarchical clustering was used to identify clinical and inflammatory biomarkers important in determining disease cluster membership in mild and moderate persistent asthmatics. In a subset of participants, GC sensitivity was assessed via expression of GC receptor alpha (GCRα) and induction of MAP kinase phosphatase-1 (MKP-1) expression by dexamethasone. Four asthma clusters were identified, with body mass index (BMI, kg/m(2)) and severity of asthma symptoms (AEQ score) the most significant determinants of cluster membership (F = 57.1, p<0.0001 and F = 44.8, p<0.0001, respectively). Two clusters were composed of predominantly obese individuals; these two obese asthma clusters differed from one another with regard to age of asthma onset, measures of asthma symptoms (AEQ) and control (ACQ), exhaled nitric oxide concentration (F(E)NO) and airway hyperresponsiveness (methacholine PC(20)) but were similar with regard to measures of lung function (FEV(1) (%) and FEV(1)/FVC), airway eosinophilia, IgE, leptin, adiponectin and C-reactive protein (hsCRP). Members of obese clusters demonstrated evidence of reduced expression of GCRα, a finding which was correlated with a reduced induction of MKP-1 expression by dexamethasone CONCLUSIONS AND SIGNIFICANCE: Obesity is an important determinant of asthma phenotype in adults. There is heterogeneity in expression of clinical and inflammatory biomarkers of asthma across obese individuals. Reduced expression of the dominant functional isoform of the GCR may mediate GC insensitivity in obese asthmatics.

Indexed as

AdultAsthmaBiomarkersBody Mass IndexBronchial HyperreactivityCluster AnalysisCohort StudiesFemaleForced Expiratory VolumeGlucocorticoidsHumansInflammation MediatorsMaleMiddle AgedObesityPhenotypeBiomarkersglucocorticoid receptor alphaGlucocorticoidsInflammation MediatorsReceptors, Glucocorticoid

Identifiers

PMID22606276
PMCPMC3350517
OpenAlexW2003900544

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.